Expert Cancer Panel: Stage III multiple myeloma on lenalidomide develops extramedullary plasmacytoma

2 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Recorded on 5/22/2021

65-year-old female with stage 3 multiple myeloma in remission on lenalidomide develops an extramedullary plasmacytoma.

Summary:
- Recommend repeat full staging with PET/CT in setting of focal relapse
- Consider enrollment in clinical trial if eligible
- Recommend systemic treatment with anti-cd38 antibody (daratumumab), potent IMID (pomalidomide), and steroid (dexamethasone)


At PrecisCa, we are dedicated to providing expert second opinions for cancer patients to ensure they receive the best possible care. Our videos cover a wide range of topics related to oncology, including in-depth discussions on different types of cancer, treatment options, patient stories, and the latest advancements in cancer research. Whether you're a patient, caregiver, or simply seeking to expand your knowledge, our goal is to support you on your healthcare journey.

Visit our website: https://www.PrecisCa.com for more detailed information and personalized second opinions.

Stay connected with us:
Facebook: / precisca.oncology
Twitter: https://twitter.com/precisca_?lang=en
-Instagram: / precisca_oncology
-LinkedIn: / precisca

Don't forget to subscribe to our channel for regular updates and new videos. Hit the bell icon to receive notifications every time we upload. #Oncology #CancerCare #CancerSupport #CancerResearch #Health #Healthcare #CancerTreatment #CancerAwareness #PatientCare #MedicalAdvice #PrecisCa
Category
Oncology
Be the first to comment

Up Next